Aibotics, Inc. (AIBT) stock
AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Aibotics EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Aibotics's EPS for the twelve months ending Jun 30, 2022 was -$0.48. For fiscal 2019 it was $0.00.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0.00 | – |
| FY2018 | Dec 31, 2018 | $0.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -$0.03 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.09 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.19 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.17 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.01 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.00 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.02 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.01 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.01 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.00 | – |
| Q4 FY2019 | Dec 31, 2019 | $0.00 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.00 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.00 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.00 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.00 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?